25 XP   0   0   10

Beijing Tiantan Biological Products Corp Ltd
Buy, Hold or Sell?

Let's analyse Beijing Tiantan Biological Products Corp Ltd together

PenkeI guess you are interested in Beijing Tiantan Biological Products Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing Tiantan Biological Products Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing Tiantan Biological Products Corp Ltd

I send you an email if I find something interesting about Beijing Tiantan Biological Products Corp Ltd.

Quick analysis of Beijing Tiantan Biological Products Corp Ltd (30 sec.)










What can you expect buying and holding a share of Beijing Tiantan Biological Products Corp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥7.74
Expected worth in 1 year
¥8.59
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥0.91
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
¥28.16
Expected price per share
¥25.32 - ¥31.07
How sure are you?
50%

1. Valuation of Beijing Tiantan Biological Products Corp Ltd (5 min.)




Live pricePrice per Share (EOD)

¥28.16

Intrinsic Value Per Share

¥1.94 - ¥5.68

Total Value Per Share

¥9.68 - ¥13.42

2. Growth of Beijing Tiantan Biological Products Corp Ltd (5 min.)




Is Beijing Tiantan Biological Products Corp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7b$1.5b$190.9m11.3%

How much money is Beijing Tiantan Biological Products Corp Ltd making?

Current yearPrevious yearGrowGrow %
Making money$38.3m$30.4m$7.9m20.6%
Net Profit Margin21.3%20.4%--

How much money comes from the company's main activities?

3. Financial Health of Beijing Tiantan Biological Products Corp Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#40 / 1016

Most Revenue
#80 / 1016

Most Profit
#58 / 1016

Most Efficient
#75 / 1016

What can you expect buying and holding a share of Beijing Tiantan Biological Products Corp Ltd? (5 min.)

Welcome investor! Beijing Tiantan Biological Products Corp Ltd's management wants to use your money to grow the business. In return you get a share of Beijing Tiantan Biological Products Corp Ltd.

What can you expect buying and holding a share of Beijing Tiantan Biological Products Corp Ltd?

First you should know what it really means to hold a share of Beijing Tiantan Biological Products Corp Ltd. And how you can make/lose money.

Speculation

The Price per Share of Beijing Tiantan Biological Products Corp Ltd is ¥28.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beijing Tiantan Biological Products Corp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beijing Tiantan Biological Products Corp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.74. Based on the TTM, the Book Value Change Per Share is ¥0.21 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beijing Tiantan Biological Products Corp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.020.1%0.020.1%0.020.1%0.010.0%
Usd Book Value Change Per Share0.020.1%0.030.1%0.020.1%0.040.1%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.030.1%0.030.1%0.040.1%0.030.1%
Usd Price Per Share4.28-3.75-3.21-4.14-4.10-
Price to Earnings Ratio57.29-41.49-48.28-68.35-118.70-
Price-to-Total Gains Ratio184.59-127.99-146.20-184.15-173.27-
Price to Book Ratio4.00-3.65-3.53-6.81-12.73-
Price-to-Total Gains Ratio184.59-127.99-146.20-184.15-173.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.891712
Number of shares256
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.04
Usd Total Gains Per Share0.030.04
Gains per Quarter (256 shares)8.019.64
Gains per Year (256 shares)32.0438.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12302223629
24605457268
3690867108107
4812011810144146
51015015012181185
61218018215217224
71421021417253263
81624024620289302
91827027822325341
102030031024361380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.00.04.090.0%82.00.06.093.2%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.03.00.092.5%72.016.00.081.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%68.00.020.077.3%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%80.08.00.090.9%

Fundamentals of Beijing Tiantan Biological Products Corp Ltd

About Beijing Tiantan Biological Products Corp Ltd

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include human albumin; intravenous human immunoglobulin; tetanus human immunoglobulin; rabies patient immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; and human prothrombin complex blood products. The company was founded in 1919 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. is a subsidiary of China National Biotec Group Company Limited.

Fundamental data was last updated by Penke on 2024-04-17 05:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Beijing Tiantan Biological Products Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beijing Tiantan Biological Products Corp Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 19.2% means that ¥0.19 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 19.2%. The company is making a huge profit. +2
  • The TTM is 21.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.2%TTM21.3%-2.1%
TTM21.3%YOY20.4%+0.9%
TTM21.3%5Y19.5%+1.8%
5Y19.5%10Y21.2%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.2%-197.2%+216.4%
TTM21.3%-210.4%+231.7%
YOY20.4%-279.3%+299.7%
5Y19.5%-436.8%+456.3%
10Y21.2%-599.3%+620.5%
1.1.2. Return on Assets

Shows how efficient Beijing Tiantan Biological Products Corp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • 1.6% Return on Assets means that Beijing Tiantan Biological Products Corp Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM2.0%-0.4%
TTM2.0%YOY1.8%+0.2%
TTM2.0%5Y2.1%-0.1%
5Y2.1%10Y2.4%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-13.6%+15.2%
TTM2.0%-12.9%+14.9%
YOY1.8%-11.9%+13.7%
5Y2.1%-14.2%+16.3%
10Y2.4%-16.2%+18.6%
1.1.3. Return on Equity

Shows how efficient Beijing Tiantan Biological Products Corp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • 2.3% Return on Equity means Beijing Tiantan Biological Products Corp Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.9%-0.7%
TTM2.9%YOY2.6%+0.3%
TTM2.9%5Y3.2%-0.3%
5Y3.2%10Y3.7%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-17.0%+19.3%
TTM2.9%-16.1%+19.0%
YOY2.6%-15.4%+18.0%
5Y3.2%-20.0%+23.2%
10Y3.7%-21.1%+24.8%

1.2. Operating Efficiency of Beijing Tiantan Biological Products Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beijing Tiantan Biological Products Corp Ltd is operating .

  • Measures how much profit Beijing Tiantan Biological Products Corp Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM16.6%-16.6%
TTM16.6%YOY30.6%-14.0%
TTM16.6%5Y27.8%-11.3%
5Y27.8%10Y16.0%+11.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM16.6%-224.4%+241.0%
YOY30.6%-288.4%+319.0%
5Y27.8%-475.2%+503.0%
10Y16.0%-624.7%+640.7%
1.2.2. Operating Ratio

Measures how efficient Beijing Tiantan Biological Products Corp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ¥1.16 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 1.159. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.161. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.159TTM1.161-0.001
TTM1.161YOY1.203-0.043
TTM1.1615Y1.195-0.035
5Y1.19510Y0.871+0.324
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1592.997-1.838
TTM1.1613.247-2.086
YOY1.2033.766-2.563
5Y1.1955.675-4.480
10Y0.8717.857-6.986

1.3. Liquidity of Beijing Tiantan Biological Products Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beijing Tiantan Biological Products Corp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.92 means the company has ¥5.92 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 5.915. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.157. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.915TTM5.157+0.758
TTM5.157YOY6.672-1.515
TTM5.1575Y6.088-0.931
5Y6.08810Y3.489+2.598
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9153.930+1.985
TTM5.1574.251+0.906
YOY6.6725.436+1.236
5Y6.0886.045+0.043
10Y3.4896.363-2.874
1.3.2. Quick Ratio

Measures if Beijing Tiantan Biological Products Corp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off ¥0.01 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 0.014. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.377. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.014TTM0.377-0.363
TTM0.377YOY0.903-0.526
TTM0.3775Y0.624-0.247
5Y0.62410Y0.497+0.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0143.629-3.615
TTM0.3774.065-3.688
YOY0.9035.397-4.494
5Y0.6245.993-5.369
10Y0.4976.277-5.780

1.4. Solvency of Beijing Tiantan Biological Products Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beijing Tiantan Biological Products Corp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Beijing Tiantan Biological Products Corp Ltd assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.128. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.128-0.027
TTM0.128YOY0.130-0.002
TTM0.1285Y0.161-0.033
5Y0.16110Y0.301-0.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1010.332-0.231
TTM0.1280.334-0.206
YOY0.1300.268-0.138
5Y0.1610.366-0.205
10Y0.3010.390-0.089
1.4.2. Debt to Equity Ratio

Measures if Beijing Tiantan Biological Products Corp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.6% means that company has ¥0.15 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The MRQ is 0.146. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.191. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.146TTM0.191-0.045
TTM0.191YOY0.192-0.002
TTM0.1915Y0.254-0.064
5Y0.25410Y0.734-0.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1460.381-0.235
TTM0.1910.390-0.199
YOY0.1920.334-0.142
5Y0.2540.434-0.180
10Y0.7340.466+0.268

2. Market Valuation of Beijing Tiantan Biological Products Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Beijing Tiantan Biological Products Corp Ltd generates.

  • Above 15 is considered overpriced but always compare Beijing Tiantan Biological Products Corp Ltd to the Biotechnology industry mean.
  • A PE ratio of 57.29 means the investor is paying ¥57.29 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The EOD is 52.140. Based on the earnings, the company is expensive. -2
  • The MRQ is 57.288. Based on the earnings, the company is expensive. -2
  • The TTM is 41.486. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD52.140MRQ57.288-5.147
MRQ57.288TTM41.486+15.802
TTM41.486YOY48.285-6.799
TTM41.4865Y68.354-26.868
5Y68.35410Y118.705-50.351
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD52.140-2.315+54.455
MRQ57.288-2.560+59.848
TTM41.486-2.664+44.150
YOY48.285-4.122+52.407
5Y68.354-6.258+74.612
10Y118.705-6.108+124.813
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The EOD is -39.371. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -43.258. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 6.018. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-39.371MRQ-43.258+3.887
MRQ-43.258TTM6.018-49.276
TTM6.018YOY-63.274+69.292
TTM6.0185Y-22.800+28.818
5Y-22.80010Y-38.131+15.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-39.371-3.067-36.304
MRQ-43.258-3.251-40.007
TTM6.018-3.545+9.563
YOY-63.274-5.595-57.679
5Y-22.800-8.315-14.485
10Y-38.131-8.708-29.423
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beijing Tiantan Biological Products Corp Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.00 means the investor is paying ¥4.00 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Beijing Tiantan Biological Products Corp Ltd:

  • The EOD is 3.638. Based on the equity, the company is fair priced.
  • The MRQ is 3.997. Based on the equity, the company is fair priced.
  • The TTM is 3.646. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.638MRQ3.997-0.359
MRQ3.997TTM3.646+0.351
TTM3.646YOY3.528+0.118
TTM3.6465Y6.814-3.167
5Y6.81410Y12.732-5.918
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.6381.905+1.733
MRQ3.9972.111+1.886
TTM3.6462.095+1.551
YOY3.5282.836+0.692
5Y6.8143.443+3.371
10Y12.7323.794+8.938
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing Tiantan Biological Products Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1670.212-21%0.165+1%0.255-35%0.160+4%
Book Value Per Share--7.7407.434+4%6.595+17%5.189+49%3.444+125%
Current Ratio--5.9155.157+15%6.672-11%6.088-3%3.489+70%
Debt To Asset Ratio--0.1010.128-21%0.130-22%0.161-37%0.301-66%
Debt To Equity Ratio--0.1460.191-23%0.192-24%0.254-43%0.734-80%
Dividend Per Share--0.0010.014-95%0.024-97%0.017-96%0.033-98%
Eps--0.1350.168-20%0.134+1%0.121+11%0.095+42%
Free Cash Flow Per Share---0.1790.200-190%-0.035-81%0.035-614%0.032-657%
Free Cash Flow To Equity Per Share---0.1790.189-195%-0.092-49%0.116-255%0.108-265%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--5.680--------
Intrinsic Value_10Y_min--1.943--------
Intrinsic Value_1Y_max--0.245--------
Intrinsic Value_1Y_min--0.141--------
Intrinsic Value_3Y_max--0.983--------
Intrinsic Value_3Y_min--0.472--------
Intrinsic Value_5Y_max--2.019--------
Intrinsic Value_5Y_min--0.855--------
Market Cap46402330951.680-10%50983242885.12044713325652.480+14%38262149314.560+33%49363453846.986+3%48902487225.109+4%
Net Profit Margin--0.1920.213-10%0.204-6%0.195-1%0.212-9%
Operating Margin---0.166-100%0.306-100%0.278-100%0.160-100%
Operating Ratio--1.1591.1610%1.203-4%1.195-3%0.871+33%
Pb Ratio3.638-10%3.9973.646+10%3.528+13%6.814-41%12.732-69%
Pe Ratio52.140-10%57.28841.486+38%48.285+19%68.354-16%118.705-52%
Price Per Share28.160-10%30.94027.135+14%23.220+33%29.957+3%29.677+4%
Price To Free Cash Flow Ratio-39.371+9%-43.2586.018-819%-63.274+46%-22.800-47%-38.131-12%
Price To Total Gains Ratio168.004-10%184.590127.994+44%146.199+26%184.151+0%173.269+7%
Quick Ratio--0.0140.377-96%0.903-98%0.624-98%0.497-97%
Return On Assets--0.0160.020-21%0.018-11%0.021-24%0.024-34%
Return On Equity--0.0230.029-23%0.026-13%0.032-30%0.037-40%
Total Gains Per Share--0.1680.226-26%0.189-11%0.272-38%0.193-13%
Usd Book Value--1762653930.8521692855301.344+4%1501922872.693+17%1181722420.362+49%784229407.148+125%
Usd Book Value Change Per Share--0.0230.029-21%0.023+1%0.035-35%0.022+4%
Usd Book Value Per Share--1.0701.027+4%0.911+17%0.717+49%0.476+125%
Usd Dividend Per Share--0.0000.002-95%0.003-97%0.002-96%0.005-98%
Usd Eps--0.0190.023-20%0.018+1%0.017+11%0.013+42%
Usd Free Cash Flow---40720265.52045469044.282-190%-7878006.842-81%7919647.951-614%6583264.780-719%
Usd Free Cash Flow Per Share---0.0250.028-190%-0.005-81%0.005-614%0.004-657%
Usd Free Cash Flow To Equity Per Share---0.0250.026-195%-0.013-49%0.016-255%0.015-265%
Usd Market Cap6412802137.522-10%7045884166.7246179381605.173+14%5287829035.272+33%6822029321.654+3%6758323734.510+4%
Usd Price Per Share3.892-10%4.2763.750+14%3.209+33%4.140+3%4.101+4%
Usd Profit--30747867.85238346651.034-20%30439552.025+1%27647119.586+11%21644004.954+42%
Usd Revenue--160096311.082178984264.182-11%147228074.721+9%140144173.207+14%105458799.784+52%
Usd Total Gains Per Share--0.0230.031-26%0.026-11%0.038-38%0.027-13%
 EOD+3 -5MRQTTM+12 -23YOY+16 -195Y+17 -1810Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Beijing Tiantan Biological Products Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1552.140
Price to Book Ratio (EOD)Between0-13.638
Net Profit Margin (MRQ)Greater than00.192
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.014
Current Ratio (MRQ)Greater than15.915
Debt to Asset Ratio (MRQ)Less than10.101
Debt to Equity Ratio (MRQ)Less than10.146
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.016
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Beijing Tiantan Biological Products Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.598
Ma 20Greater thanMa 5026.794
Ma 50Greater thanMa 10027.328
Ma 100Greater thanMa 20028.717
OpenGreater thanClose28.160
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  81,17990,081171,259-134,31036,949283,034319,983-472,496-152,513
Interest Expense  7474,8455,592-2,6602,933-1,5461,387-1,778-392



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets14,188,057
Total Liabilities1,433,687
Total Stockholder Equity9,822,579
 As reported
Total Liabilities 1,433,687
Total Stockholder Equity+ 9,822,579
Total Assets = 14,188,057

Assets

Total Assets14,188,057
Total Current Assets7,569,186
Long-term Assets6,618,871
Total Current Assets
Cash And Cash Equivalents 4,554,949
Net Receivables 17,866
Inventory 2,844,499
Other Current Assets 1,262
Total Current Assets  (as reported)7,569,186
Total Current Assets  (calculated)7,418,576
+/- 150,610
Long-term Assets
Property Plant Equipment 4,886,337
Goodwill 173,925
Intangible Assets 1,050,473
Long-term Assets Other 139,974
Long-term Assets  (as reported)6,618,871
Long-term Assets  (calculated)6,250,709
+/- 368,163

Liabilities & Shareholders' Equity

Total Current Liabilities1,279,620
Long-term Liabilities154,067
Total Stockholder Equity9,822,579
Total Current Liabilities
Accounts payable 179,097
Other Current Liabilities 11,580
Total Current Liabilities  (as reported)1,279,620
Total Current Liabilities  (calculated)190,677
+/- 1,088,943
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt24,415
Long-term Liabilities Other 1,240
Long-term Liabilities  (as reported)154,067
Long-term Liabilities  (calculated)25,655
+/- 128,412
Total Stockholder Equity
Retained Earnings 5,120,477
Total Stockholder Equity (as reported)9,822,579
Total Stockholder Equity (calculated)5,120,477
+/- 4,702,102
Other
Capital Stock1,647,810
Common Stock Shares Outstanding 1,647,810
Net Invested Capital 9,822,579
Net Working Capital 6,289,566
Property Plant and Equipment Gross 4,886,337



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
417,821
445,984
448,957
463,321
468,633
463,444
469,967
504,770
461,037
470,746
753,220
758,948
782,729
801,115
757,947
762,493
774,761
782,191
808,125
848,763
863,770
894,289
922,552
1,064,553
1,026,338
1,024,925
1,051,702
1,094,911
1,087,311
1,216,631
1,268,239
1,196,329
1,320,736
1,398,250
1,443,493
2,161,020
2,075,700
2,200,710
2,346,201
2,448,094
2,498,131
2,976,499
3,035,547
3,224,041
3,350,995
4,003,793
4,041,488
4,806,051
5,007,920
5,216,661
5,503,488
5,634,539
6,056,031
6,797,676
6,376,683
6,015,448
6,003,012
5,764,523
5,806,372
5,631,926
5,628,114
5,748,924
5,822,507
5,783,232
5,936,570
3,317,911
3,444,033
3,665,745
4,613,193
4,670,841
4,902,169
5,066,971
5,510,515
5,721,880
6,193,868
6,314,412
6,698,622
7,266,539
7,608,079
7,541,052
7,987,018
11,287,552
11,615,500
11,577,632
11,850,882
12,262,274
12,912,060
12,940,709
13,512,920
13,881,244
14,596,788
14,188,057
14,188,05714,596,78813,881,24413,512,92012,940,70912,912,06012,262,27411,850,88211,577,63211,615,50011,287,5527,987,0187,541,0527,608,0797,266,5396,698,6226,314,4126,193,8685,721,8805,510,5155,066,9714,902,1694,670,8414,613,1933,665,7453,444,0333,317,9115,936,5705,783,2325,822,5075,748,9245,628,1145,631,9265,806,3725,764,5236,003,0126,015,4486,376,6836,797,6766,056,0315,634,5395,503,4885,216,6615,007,9204,806,0514,041,4884,003,7933,350,9953,224,0413,035,5472,976,4992,498,1312,448,0942,346,2012,200,7102,075,7002,161,0201,443,4931,398,2501,320,7361,196,3291,268,2391,216,6311,087,3111,094,9111,051,7021,024,9251,026,3381,064,553922,552894,289863,770848,763808,125782,191774,761762,493757,947801,115782,729758,948753,220470,746461,037504,770469,967463,444468,633463,321448,957445,984417,821
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,206,570
3,386,662
3,432,884
3,747,702
3,861,522
4,173,094
4,046,354
4,340,524
4,772,414
4,950,335
4,656,188
4,846,974
7,964,108
7,954,670
7,545,726
7,607,310
7,763,985
7,634,247
7,270,712
7,626,285
7,034,910
8,123,914
7,569,186
7,569,1868,123,9147,034,9107,626,2857,270,7127,634,2477,763,9857,607,3107,545,7267,954,6707,964,1084,846,9744,656,1884,950,3354,772,4144,340,5244,046,3544,173,0943,861,5223,747,7023,432,8843,386,6623,206,570000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,050,331
1,164,348
1,249,501
1,537,892
1,478,239
1,640,658
1,413,353
1,913,610
2,237,005
2,201,345
1,748,117
1,857,040
4,859,595
4,745,604
4,329,748
4,268,246
4,485,341
4,213,222
3,712,890
4,135,913
3,748,523
5,060,308
4,554,949
4,554,9495,060,3083,748,5234,135,9133,712,8904,213,2224,485,3414,268,2464,329,7484,745,6044,859,5951,857,0401,748,1172,201,3452,237,0051,913,6101,413,3531,640,6581,478,2391,537,8921,249,5011,164,3481,050,331000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
53,334
47,719
61,808
40,583
64,192
53,985
56,516
45,051
48,775
57,968
63,961
57,161
61,350
72,447
71,611
55,140
83,714
102,373
108,072
78,294
93,565
111,767
119,568
130,718
159,980
140,006
165,097
124,558
152,455
185,035
246,462
109,967
197,646
192,982
183,251
146,028
193,994
236,161
279,743
159,532
215,438
243,354
343,503
274,213
413,653
455,831
472,628
376,453
473,395
533,964
485,301
370,080
486,761
520,277
437,726
292,052
353,677
368,153
342,972
229,688
274,149
284,587
344,534
315,446
399,054
51,213
118,480
225,222
443,097
370,485
436,182
450,344
15,308
16,240
14,804
659,221
506,561
507,899
740,630
712,518
721,767
833,078
890,263
1,049,557
991,026
920,671
988,145
1,200,945
1,148,216
942,622
27,175
17,866
17,86627,175942,6221,148,2161,200,945988,145920,671991,0261,049,557890,263833,078721,767712,518740,630507,899506,561659,22114,80416,24015,308450,344436,182370,485443,097225,222118,48051,213399,054315,446344,534284,587274,149229,688342,972368,153353,677292,052437,726520,277486,761370,080485,301533,964473,395376,453472,628455,831413,653274,213343,503243,354215,438159,532279,743236,161193,994146,028183,251192,982197,646109,967246,462185,035152,455124,558165,097140,006159,980130,718119,568111,76793,56578,294108,072102,37383,71455,14071,61172,44761,35057,16163,96157,96848,77545,05156,51653,98564,19240,58361,80847,71953,334
       Other Current Assets 
7,597
14,907
13,185
4,047
5,883
5,756
6,344
7,587
6,609
11,323
17,857
16,627
18,599
31,105
26,523
5,581
6,889
14,969
24,068
7,047
11,934
75,193
17,698
17,042
27,970
20,747
23,617
11,676
82,980
103,243
104,544
67,935
73,499
82,298
93,108
82,815
94,831
98,523
114,112
104,728
94,548
84,796
89,597
16,348
25,033
18,047
37,772
22,532
32,090
11,761
54,887
25,133
45,904
36,822
54,564
20,421
24,062
21,018
63,008
20,308
13,474
28,787
38,285
25,931
20,187
13,736
12,216
14,783
42,662
41,656
46,564
19,874
10,758
4,670
3,055
22,846
26,798
27,674
33,995
23,642
46,859
40,452
49,710
22,274
30,509
44,846
44,887
24,875
61,476
24,862
742
1,262
1,26274224,86261,47624,87544,88744,84630,50922,27449,71040,45246,85923,64233,99527,67426,79822,8463,0554,67010,75819,87446,56441,65642,66214,78312,21613,73620,18725,93138,28528,78713,47420,30863,00821,01824,06220,42154,56436,82245,90425,13354,88711,76132,09022,53237,77218,04725,03316,34889,59784,79694,548104,728114,11298,52394,83182,81593,10882,29873,49967,935104,544103,24382,98011,67623,61720,74727,97017,04217,69875,19311,9347,04724,06814,9696,8895,58126,52331,10518,59916,62717,85711,3236,6097,5876,3445,7565,8834,04713,18514,9077,597
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,762,813
1,860,358
2,020,774
2,268,058
2,358,098
2,494,125
2,657,744
2,884,863
3,140,044
3,323,444
3,660,830
4,031,906
4,243,572
4,498,288
5,277,812
5,669,998
5,886,635
6,846,335
6,472,874
6,618,871
6,618,8716,472,8746,846,3355,886,6355,669,9985,277,8124,498,2884,243,5724,031,9063,660,8303,323,4443,140,0442,884,8632,657,7442,494,1252,358,0982,268,0582,020,7741,860,3581,762,813000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
183,924
188,081
191,078
210,548
213,435
220,552
224,677
223,012
221,134
219,100
252,906
254,171
255,588
256,781
266,828
303,613
298,083
294,627
290,458
305,843
303,590
313,837
326,501
369,077
370,086
378,037
359,384
401,410
382,380
409,807
394,921
451,989
440,341
460,466
471,017
907,428
785,591
954,547
847,324
1,167,725
1,036,720
1,395,613
1,333,388
1,722,023
1,556,128
2,047,635
1,951,524
3,010,928
2,842,771
3,109,962
3,002,159
3,404,622
3,256,703
3,344,966
3,392,496
3,406,204
3,556,718
3,561,095
3,559,769
3,461,108
3,419,718
3,391,400
3,356,406
3,351,534
3,364,839
431,223
446,126
446,241
921,092
916,165
923,536
986,874
1,023,315
1,052,878
1,187,422
1,559,791
1,626,268
1,712,700
1,859,656
1,997,286
2,156,703
2,215,301
2,428,337
2,630,595
2,823,459
3,041,419
3,728,090
4,054,581
4,249,912
4,418,773
4,634,027
4,886,337
4,886,3374,634,0274,418,7734,249,9124,054,5813,728,0903,041,4192,823,4592,630,5952,428,3372,215,3012,156,7031,997,2861,859,6561,712,7001,626,2681,559,7911,187,4221,052,8781,023,315986,874923,536916,165921,092446,241446,126431,2233,364,8393,351,5343,356,4063,391,4003,419,7183,461,1083,559,7693,561,0953,556,7183,406,2043,392,4963,344,9663,256,7033,404,6223,002,1593,109,9622,842,7713,010,9281,951,5242,047,6351,556,1281,722,0231,333,3881,395,6131,036,7201,167,725847,324954,547785,591907,428471,017460,466440,341451,989394,921409,807382,380401,410359,384378,037370,086369,077326,501313,837303,590305,843290,458294,627298,083303,613266,828256,781255,588254,171252,906219,100221,134223,012224,677220,552213,435210,548191,078188,081183,924
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,987
93,987
93,987
95,553
95,526
95,526
95,526
102,939
102,939
115,012
115,012
115,012
115,012
115,012
115,012
132,378
127,934
127,934
127,934
127,934
127,934
169,999
173,925
173,925
173,925
173,925
173,925
173,925173,925173,925173,925173,925169,999127,934127,934127,934127,934127,934132,378115,012115,012115,012115,012115,012115,012102,939102,93995,52695,52695,52695,55393,98793,98793,98700000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,839
81,839
81,839
80,928
80,928
88,728
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000088,72880,92880,92881,83981,83961,839000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
3,921
13,739
13,368
13,194
9,804
10,855
10,388
9,921
9,454
35,093
32,805
30,516
28,228
25,940
23,651
21,363
19,074
16,786
14,497
12,209
9,983
10,980
13,121
6,821
19,257
3,643
17,158
2,878
16,485
2,528
15,979
106
13,642
16,244
140,197
15,172
216,883
14,174
216,178
13,089
214,267
12,054
211,268
11,738
208,025
10,639
211,990
12,467
209,500
12,368
201,841
199,957
198,308
197,906
195,995
194,401
193,953
192,003
190,054
191,928
189,933
188,317
196,835
223,314
221,002
219,060
347,004
254,901
249,456
287,070
312,273
82,906
327,419
330,860
334,307
368,027
392,711
393,677
453,663
498,632
547,817
701,071
724,390
760,205
806,965
929,945
981,772
1,013,145
1,041,443
1,050,473
1,050,4731,041,4431,013,145981,772929,945806,965760,205724,390701,071547,817498,632453,663393,677392,711368,027334,307330,860327,41982,906312,273287,070249,456254,901347,004219,060221,002223,314196,835188,317189,933191,928190,054192,003193,953194,401195,995197,906198,308199,957201,84112,368209,50012,467211,99010,639208,02511,738211,26812,054214,26713,089216,17814,174216,88315,172140,19716,24413,64210615,9792,52816,4852,87817,1583,64319,2576,82113,12110,9809,98312,20914,49716,78619,07421,36323,65125,94028,22830,51632,80535,0939,4549,92110,38810,8559,80413,19413,36813,7393,92100
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,449
232,779
220,050
51,763
67,403
60,207
1,915,608
86,319
105,723
192,168
251,194
250,800
245,457
233,522
242,653
157,058
130,024
883,730
245,196
139,974
139,974245,196883,730130,024157,058242,653233,522245,457250,800251,194192,168105,72386,3191,915,60860,20767,40351,763220,050232,779193,449000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
114,432
166,773
143,507
173,638
165,162
168,496
167,313
215,726
163,183
152,653
157,581
159,244
165,552
166,356
123,664
125,704
158,219
142,621
149,464
179,670
168,420
223,705
281,431
356,199
343,295
370,473
362,531
369,336
357,957
501,067
564,301
439,353
539,505
563,479
622,376
1,211,887
1,044,707
1,089,884
1,130,973
1,305,938
1,271,314
1,663,936
1,559,899
1,777,893
1,817,813
2,422,297
2,410,153
3,028,900
3,179,258
3,223,323
3,377,887
3,458,214
3,765,157
4,406,824
3,968,816
3,797,816
3,752,581
3,519,142
3,550,127
3,395,687
3,379,354
3,491,372
3,460,634
3,342,268
3,387,274
397,426
410,441
481,456
610,394
620,004
627,280
720,187
967,218
985,668
1,208,074
1,137,050
1,323,450
1,670,892
1,758,034
1,510,097
1,728,591
1,573,000
1,601,812
1,310,769
1,408,465
1,603,470
1,898,625
1,584,370
1,797,598
1,833,094
2,117,372
1,433,687
1,433,6872,117,3721,833,0941,797,5981,584,3701,898,6251,603,4701,408,4651,310,7691,601,8121,573,0001,728,5911,510,0971,758,0341,670,8921,323,4501,137,0501,208,074985,668967,218720,187627,280620,004610,394481,456410,441397,4263,387,2743,342,2683,460,6343,491,3723,379,3543,395,6873,550,1273,519,1423,752,5813,797,8163,968,8164,406,8243,765,1573,458,2143,377,8873,223,3233,179,2583,028,9002,410,1532,422,2971,817,8131,777,8931,559,8991,663,9361,271,3141,305,9381,130,9731,089,8841,044,7071,211,887622,376563,479539,505439,353564,301501,067357,957369,336362,531370,473343,295356,199281,431223,705168,420179,670149,464142,621158,219125,704123,664166,356165,552159,244157,581152,653163,183215,726167,313168,496165,162173,638143,507166,773114,432
   > Total Current Liabilities 
114,432
166,773
143,508
173,637
165,162
168,496
167,312
215,726
163,183
152,653
157,581
159,244
146,052
138,856
96,165
83,904
112,419
96,821
101,664
93,071
81,820
137,105
191,831
247,465
234,583
261,739
253,447
231,802
261,723
364,834
396,286
283,125
370,506
393,364
450,971
1,052,868
911,079
926,802
947,136
823,998
769,438
976,623
720,827
946,561
934,466
1,004,069
959,779
1,611,293
1,752,451
1,702,352
1,893,922
1,848,919
1,741,318
2,715,401
2,744,111
2,550,970
2,475,597
1,824,554
1,331,362
1,422,929
1,437,419
1,385,675
1,398,735
1,194,989
1,293,309
189,405
202,831
274,322
600,568
611,760
619,908
482,405
580,394
599,280
725,271
651,941
638,620
1,065,417
1,143,410
939,360
1,121,802
1,020,948
1,050,300
809,578
908,017
1,154,916
1,439,481
1,157,348
1,365,270
1,472,753
1,867,929
1,279,620
1,279,6201,867,9291,472,7531,365,2701,157,3481,439,4811,154,916908,017809,5781,050,3001,020,9481,121,802939,3601,143,4101,065,417638,620651,941725,271599,280580,394482,405619,908611,760600,568274,322202,831189,4051,293,3091,194,9891,398,7351,385,6751,437,4191,422,9291,331,3621,824,5542,475,5972,550,9702,744,1112,715,4011,741,3181,848,9191,893,9221,702,3521,752,4511,611,293959,7791,004,069934,466946,561720,827976,623769,438823,998947,136926,802911,0791,052,868450,971393,364370,506283,125396,286364,834261,723231,802253,447261,739234,583247,465191,831137,10581,82093,071101,66496,821112,41983,90496,165138,856146,052159,244157,581152,653163,183215,726167,312168,496165,162173,637143,508166,773114,432
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200,114
200,114
200,125
200,125
0
0
0
0
0
0
0
0
0
0
0
00000000000200,125200,125200,114200,11400000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,755
1,179
4,153
4,890
4,545
7,640
5,380
15,714
9,940
5,031
4,484
11,121
4,061
4,540
3,656
11,398
8,447
7,840
7,175
3,813
1,023
4,771
619
6,029
4,420
5,935
3,624
3,547
3,808
4,057
4,205
5,925
5,857
6,792
7,350
47,123
61,028
46,602
34,114
43,616
30,955
29,672
54,349
35,043
25,459
104,494
171,709
171,112
155,585
187,791
182,725
157,586
165,495
118,678
117,770
115,224
141,359
116,251
126,930
128,679
138,813
127,253
120,338
122,638
121,029
28,988
21,800
24,291
94,236
95,720
88,508
56,214
62,897
86,153
85,325
49,935
57,447
57,245
45,522
45,857
71,824
73,175
69,352
73,703
62,678
101,848
89,625
69,387
86,454
97,844
161,186
179,097
179,097161,18697,84486,45469,38789,625101,84862,67873,70369,35273,17571,82445,85745,52257,24557,44749,93585,32586,15362,89756,21488,50895,72094,23624,29121,80028,988121,029122,638120,338127,253138,813128,679126,930116,251141,359115,224117,770118,678165,495157,586182,725187,791155,585171,112171,709104,49425,45935,04354,34929,67230,95543,61634,11446,60261,02847,1237,3506,7925,8575,9254,2054,0573,8083,5473,6245,9354,4206,0296194,7711,0233,8137,1757,8408,44711,3983,6564,5404,06111,1214,4845,0319,94015,7145,3807,6404,5454,8904,1531,1791,755
       Other Current Liabilities 
28,477
81,394
25,155
54,547
46,417
46,656
47,732
65,812
39,043
33,422
38,897
68,123
61,991
54,316
57,509
57,506
88,972
73,981
84,489
89,258
80,797
82,334
141,212
111,436
100,163
105,804
99,823
88,255
77,915
100,777
162,081
117,200
144,649
166,572
173,621
555,745
410,051
390,200
383,022
260,382
248,483
266,951
186,478
271,897
207,386
320,468
238,070
1,000,975
1,024,660
901,762
892,516
1,021,289
1,415,823
881,565
2,218,341
881,536
2,249,237
910,021
916,532
814,884
719,927
661,066
758,396
642,352
580,505
160,418
181,031
250,031
296,332
347,901
443,731
228,693
448,899
192,819
469,605
355,737
501,130
486,199
620,101
420,275
616,677
566,642
658,136
461,198
617,754
615,966
995,070
944,418
1,061,482
929,486
17,510
11,580
11,58017,510929,4861,061,482944,418995,070615,966617,754461,198658,136566,642616,677420,275620,101486,199501,130355,737469,605192,819448,899228,693443,731347,901296,332250,031181,031160,418580,505642,352758,396661,066719,927814,884916,532910,0212,249,237881,5362,218,341881,5651,415,8231,021,289892,516901,7621,024,6601,000,975238,070320,468207,386271,897186,478266,951248,483260,382383,022390,200410,051555,745173,621166,572144,649117,200162,081100,77777,91588,25599,823105,804100,163111,436141,21282,33480,79789,25884,48973,98188,97257,50657,50954,31661,99168,12338,89733,42239,04365,81247,73246,65646,41754,54725,15581,39428,477
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
386,824
386,387
482,803
485,109
684,830
605,475
614,624
570,737
606,789
552,052
551,512
501,191
500,448
448,553
459,144
427,022
432,328
360,340
249,443
154,067
154,067249,443360,340432,328427,022459,144448,553500,448501,191551,512552,052606,789570,737614,624605,475684,830485,109482,803386,387386,824000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
1
0
0
1
0
0
0
0
0
19,500
27,500
27,499
41,800
45,800
45,800
47,800
86,599
86,600
86,600
89,600
108,734
108,712
108,734
109,084
137,534
96,234
96,233
98,015
96,228
108,999
110,115
111,405
129,019
133,628
112,827
115,076
121,744
117,303
168,784
117,444
123,578
123,818
118,228
150,374
117,607
126,807
130,714
125,850
150,074
150,919
160,243
181,258
202,394
199,835
177,004
194,079
193,253
191,435
199,201
203,882
235,015
242,319
4,990
4,716
4,378
4,390
8,245
7,372
6,994
62,060
61,623
82,803
84,510
83,956
84,701
93,857
96,143
106,291
111,206
110,563
116,926
117,799
120,015
129,179
147,655
146,803
139,000
0
0
00139,000146,803147,655129,179120,015117,799116,926110,563111,206106,29196,14393,85784,70183,95684,51082,80361,62362,0606,9947,3728,2454,3904,3784,7164,990242,319235,015203,882199,201191,435193,253194,079177,004199,835202,394181,258160,243150,919150,074125,850130,714126,807117,607150,374118,228123,818123,578117,444168,784117,303121,744115,076112,827133,628129,019111,405110,115108,99996,22898,01596,23396,234137,534109,084108,734108,712108,73489,60086,60086,60086,59947,80045,80045,80041,80027,49927,50019,500000001001000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,069
13,189
15,414
24,899
31,619
53,540
61,633
69,393
110,725
140,876
174,075
190,143
221,636
273,281
362,460
383,119
406,487
430,336
552,692
587,079
616,698
0
0
00616,698587,079552,692430,336406,487383,119362,460273,281221,636190,143174,075140,876110,72569,39361,63353,54031,61924,89915,41413,18913,069000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
302,933
278,729
304,958
289,143
302,920
294,329
302,040
288,522
297,413
317,569
595,115
599,177
616,647
634,230
633,752
636,259
616,008
639,037
658,056
668,556
694,839
670,012
640,464
656,098
625,225
594,811
627,730
648,032
666,666
642,844
630,846
664,083
703,512
741,387
725,029
798,662
871,275
929,171
1,057,897
1,054,972
1,120,055
1,124,501
1,270,998
1,288,926
1,360,254
1,391,781
1,428,390
1,554,006
1,650,192
1,777,922
1,891,379
1,926,034
2,020,849
2,155,063
2,144,733
1,940,977
1,953,075
1,997,887
1,983,245
1,941,582
1,940,906
2,038,511
2,125,478
2,194,418
2,284,503
2,805,382
2,905,916
3,040,013
3,155,747
3,151,866
3,308,189
3,371,305
3,502,802
3,621,395
3,794,627
3,938,897
4,070,758
4,222,587
4,375,792
4,517,946
4,669,667
7,628,903
7,850,096
8,052,029
8,177,205
8,299,666
8,515,570
8,795,740
9,057,649
9,280,149
9,600,750
9,822,579
9,822,5799,600,7509,280,1499,057,6498,795,7408,515,5708,299,6668,177,2058,052,0297,850,0967,628,9034,669,6674,517,9464,375,7924,222,5874,070,7583,938,8973,794,6273,621,3953,502,8023,371,3053,308,1893,151,8663,155,7473,040,0132,905,9162,805,3822,284,5032,194,4182,125,4782,038,5111,940,9061,941,5821,983,2451,997,8871,953,0751,940,9772,144,7332,155,0632,020,8491,926,0341,891,3791,777,9221,650,1921,554,0061,428,3901,391,7811,360,2541,288,9261,270,9981,124,5011,120,0551,054,9721,057,897929,171871,275798,662725,029741,387703,512664,083630,846642,844666,666648,032627,730594,811625,225656,098640,464670,012694,839668,556658,056639,037616,008636,259633,752634,230616,647599,177595,115317,569297,413288,522302,040294,329302,920289,143304,958278,729302,933
   Common Stock
192,000
192,000
192,000
192,000
192,000
192,000
192,000
192,000
192,000
192,000
217,000
217,000
217,000
217,000
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
325,500
488,250
488,250
488,250
488,250
488,250
488,250
488,250
488,250
488,250
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
515,467
670,107
670,107
670,107
670,107
871,139
871,139
871,139
871,139
1,045,367
1,045,367
1,045,367
1,045,367
1,045,367
1,254,440
1,254,440
1,254,440
1,373,175
1,373,175
1,373,175
1,373,175
1,647,810
1,647,810
1,647,810
1,647,810
1,647,810
0
0
001,647,8101,647,8101,647,8101,647,8101,647,8101,373,1751,373,1751,373,1751,373,1751,254,4401,254,4401,254,4401,045,3671,045,3671,045,3671,045,3671,045,367871,139871,139871,139871,139670,107670,107670,107670,107515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467515,467488,250488,250488,250488,250488,250488,250488,250488,250488,250325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500325,500217,000217,000217,000217,000192,000192,000192,000192,000192,000192,000192,000192,000192,000192,000
   Retained Earnings 
41,929
10,116
36,537
14,443
28,088
15,352
23,582
6,929
15,820
35,975
46,203
41,508
58,978
69,548
69,070
68,680
48,429
71,458
90,477
84,816
111,098
79,616
50,068
58,576
87,173
56,758
86,927
101,059
116,878
86,929
74,932
102,983
141,117
179,186
162,828
214,581
286,485
344,381
396,168
358,348
423,431
427,878
522,874
521,547
592,875
616,850
653,460
761,251
857,437
985,168
1,098,624
1,104,956
1,341,327
1,475,541
1,465,211
1,264,369
1,276,467
1,319,279
1,304,636
1,274,346
1,273,670
1,371,274
1,458,242
1,536,123
1,635,704
1,985,771
2,086,304
2,220,501
2,226,348
2,021,431
2,177,754
2,225,697
2,109,447
2,053,813
2,227,045
2,619,006
2,750,866
2,902,695
2,846,827
2,988,988
3,140,710
3,188,557
3,409,750
3,611,683
3,736,859
3,859,320
4,075,224
4,355,394
4,617,303
4,839,804
4,900,976
5,120,477
5,120,4774,900,9764,839,8044,617,3034,355,3944,075,2243,859,3203,736,8593,611,6833,409,7503,188,5573,140,7102,988,9882,846,8272,902,6952,750,8662,619,0062,227,0452,053,8132,109,4472,225,6972,177,7542,021,4312,226,3482,220,5012,086,3041,985,7711,635,7041,536,1231,458,2421,371,2741,273,6701,274,3461,304,6361,319,2791,276,4671,264,3691,465,2111,475,5411,341,3271,104,9561,098,624985,168857,437761,251653,460616,850592,875521,547522,874427,878423,431358,348396,168344,381286,485214,581162,828179,186141,117102,98374,93286,929116,878101,05986,92756,75887,17358,57650,06879,616111,09884,81690,47771,45848,42968,68069,07069,54858,97841,50846,20335,97515,8206,92923,58215,35228,08814,44336,53710,11641,929
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 00-104-104-104-104-104-104-104-104-104-104-104-97-97-97-97-153-153-153-153-118-118000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,180,442
Cost of Revenue-2,550,721
Gross Profit2,629,7212,629,721
 
Operating Income (+$)
Gross Profit2,629,721
Operating Expense-3,457,957
Operating Income1,722,485-828,236
 
Operating Expense (+$)
Research Development139,950
Selling General Administrative375,679
Selling And Marketing Expenses0
Operating Expense3,457,957515,628
 
Net Interest Income (+$)
Interest Income55,526
Interest Expense-3,655
Other Finance Cost-2,347
Net Interest Income49,525
 
Pretax Income (+$)
Operating Income1,722,485
Net Interest Income49,525
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,798,5981,722,485
EBIT - interestExpense = -3,655
1,109,889
1,113,543
Interest Expense3,655
Earnings Before Interest and Taxes (EBIT)01,802,253
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,798,598
Tax Provision-289,140
Net Income From Continuing Ops1,509,4591,509,459
Net Income1,109,889
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-49,525
 

Technical Analysis of Beijing Tiantan Biological Products Corp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beijing Tiantan Biological Products Corp Ltd. The general trend of Beijing Tiantan Biological Products Corp Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beijing Tiantan Biological Products Corp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing Tiantan Biological Products Corp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 28.60 < 29.60 < 31.07.

The bearish price targets are: 25.75 > 25.66 > 25.32.

Tweet this
Beijing Tiantan Biological Products Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing Tiantan Biological Products Corp Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing Tiantan Biological Products Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing Tiantan Biological Products Corp Ltd. The current macd is 0.15022257.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beijing Tiantan Biological Products Corp Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Beijing Tiantan Biological Products Corp Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Beijing Tiantan Biological Products Corp Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Beijing Tiantan Biological Products Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeijing Tiantan Biological Products Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing Tiantan Biological Products Corp Ltd. The current adx is 20.75.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Beijing Tiantan Biological Products Corp Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Beijing Tiantan Biological Products Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing Tiantan Biological Products Corp Ltd. The current sar is 26.11.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Beijing Tiantan Biological Products Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing Tiantan Biological Products Corp Ltd. The current rsi is 56.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Beijing Tiantan Biological Products Corp Ltd Daily Relative Strength Index (RSI) ChartBeijing Tiantan Biological Products Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing Tiantan Biological Products Corp Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beijing Tiantan Biological Products Corp Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Beijing Tiantan Biological Products Corp Ltd Daily Stochastic Oscillator ChartBeijing Tiantan Biological Products Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing Tiantan Biological Products Corp Ltd. The current cci is 158.18.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Beijing Tiantan Biological Products Corp Ltd Daily Commodity Channel Index (CCI) ChartBeijing Tiantan Biological Products Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing Tiantan Biological Products Corp Ltd. The current cmo is 19.53.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Beijing Tiantan Biological Products Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartBeijing Tiantan Biological Products Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing Tiantan Biological Products Corp Ltd. The current willr is -20.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Beijing Tiantan Biological Products Corp Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Beijing Tiantan Biological Products Corp Ltd Daily Williams %R ChartBeijing Tiantan Biological Products Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing Tiantan Biological Products Corp Ltd.

Beijing Tiantan Biological Products Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing Tiantan Biological Products Corp Ltd. The current atr is 0.88609487.

Beijing Tiantan Biological Products Corp Ltd Daily Average True Range (ATR) ChartBeijing Tiantan Biological Products Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing Tiantan Biological Products Corp Ltd. The current obv is 507,739,537.

Beijing Tiantan Biological Products Corp Ltd Daily On-Balance Volume (OBV) ChartBeijing Tiantan Biological Products Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing Tiantan Biological Products Corp Ltd. The current mfi is 58.95.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Beijing Tiantan Biological Products Corp Ltd Daily Money Flow Index (MFI) ChartBeijing Tiantan Biological Products Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing Tiantan Biological Products Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Beijing Tiantan Biological Products Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing Tiantan Biological Products Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.598
Ma 20Greater thanMa 5026.794
Ma 50Greater thanMa 10027.328
Ma 100Greater thanMa 20028.717
OpenGreater thanClose28.160
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beijing Tiantan Biological Products Corp Ltd with someone you think should read this too:
  • Are you bullish or bearish on Beijing Tiantan Biological Products Corp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beijing Tiantan Biological Products Corp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing Tiantan Biological Products Corp Ltd

I send you an email if I find something interesting about Beijing Tiantan Biological Products Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing Tiantan Biological Products Corp Ltd.

Receive notifications about Beijing Tiantan Biological Products Corp Ltd in your mailbox!